Indications and uses
• helps prevent sunburn
ANTI-AGING SUNSCREEN BROAD SPECTRUM SPF 30
- Manufacturer
- La Prairie, Inc.
- Effective date
- 2018-09-20
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 13
- Source
- legacy-cache
- Hydrated at
- 2026-08-02 00:49:57
Label at a glance#
ProductANTI-AGING SUNSCREEN BROAD SPECTRUM SPF 30
Active ingredientAVOBENZONE, OCTINOXATE, OCTISALATE, OXYBENZONE
Label structure13 sections
Dosage and administration
• apply daily after cleansing and toning • smooth over face and throat • apply liberally 15 minutes before sun exposure • children under 6 months of age: Ask a doctor • reapply at least every 2 hours • use a water resistant sunscreen if swimming or sweating • Sun Protection Measures. Spending time in the sun increase your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen wi...
Contacts and useful links#
Websitewww.laprairie.com
www.laprairie.com
www.laprairie.comLabel contents#
Full prescribing information#
Active Ingredients
Avobenzone 2.8%
Octinoxate 7.5%
Octisalate 5.0%
Oxybenzone 4.0%
Purpose
Sunscreen
Uses
• helps prevent sunburn
Warnings
For external use only
Do not use
on damaged or broken skin
When using this product
keep out of eyes. Rinse with water to remove.
Stop use and ask a doctor if
rash occurs
Keep out of reach of children.
If product is swallowed, get medical help or contact a Poison Control Center right away.
Directions:
• apply daily after cleansing and toning • smooth over face and throat • apply liberally 15 minutes before sun exposure • children under 6 months of age: Ask a doctor • reapply at least every 2 hours • use a water resistant sunscreen if swimming or sweating • Sun Protection Measures. Spending time in the sun increase your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a Broad Spectrum SPF value of 15 or higher and other sun protection measures including: • Limit time in the sun, especially from 10 a.m. - 2 p.m. • Wear long-sleeve shirts, pants, hats and sunglasses
Inactive Ingredients:
Water(Aqua), Butylene Glycol, Isostearyl Neopentanoate, Glycerin, Coco-Glucoside, Cyclohexasiloxane, Ethoxydiglycol, Peg-100 Stearate, Isononyl Isononanoate, Glyceryl Stearate, Glycoproteins*, Panax Ginseng Root Extract*, Equisetum Arvense (Horsetail) Extract, Olea Europaea (Olive) Oil Unsapoinfiables, Ursolic Acid, Llomastat, Algin, Caprylic/Capric Triglyceride, Coconut Alcohol, Caprylic/Capryl Glucoside, Acacia Senegal Gum, Ascorbyl Tetraisopalmitate, Serine, Tocopherol, DNA, Triticum Vulgare (Wheat) Germ Oil Unsaponifiables, Carnosine, Camellia Sinensis Leaf Extract, Glycine Soja (Soybean) Oil Unsaponifiables, PEG-8, Phospholipids, Plankton Extract, Cyclopentasiloxane, Isodecyl Salicylate, Isopropylbenzyl Salicylate, Pollen Extract, Hydrolyzed Malt Extract, Propylene Glycol, Oligopeptide-5, Angelica Keiskei Extract, Oligopeptide-4, Dimethicone, Lecithin, Silybum Marianum (Lady's Thistle) Fruit Extract, Tocopheryl Linoleate/Oleate, Echium Plantagineum Seed Oil, Polymethyl Methacrylate, Lauroyl Lysine, Sodium Acrylate/Acryloyldimethyl Taurate Copolymer, Sucrose, Xanthan Gum, Disodium EDTA, Alcohol, Acrylates/C10-30 Alkyl Acrylate Crosscopolymer, Polyisobutene, Carbomer, PPG-2 Isoceteth-20 Acetate, Mica, Fragrance (Parfum), Benzyl Alcohol, Linalool, Hydroxycitronellal, Alpha-Isomethyl Ionone, Amyl Cinnamal, Hexyl Cinnamal, Evernia Furfuracea (Treemoss) Extract, Geraniol, Benzyl Benzoate, Butylphenyl Methylpropiona, Citronellol, Eugenol, Benzyl Salicylate, Limonene, Phenoxyethanol, Potassium Sorbate, Chlorphenesin, Methylparaben, Benzoic Acid, Ethylparaben *La Prairie’s exclusive Cellular Complex US Patent 5,840,309
Other Information
• Protect the product in this container from excessive heat and direct sun
Questions or comments?
Call toll free 1-800-821-5718 or visit www.laprairie.com
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
ANTI-AGING EMULSION SUNSCREEN BROAD SPECTRUM EMULSION ANTI-AGE CREME SOLAIRE LARGE SPECTRE SPF 30 la prairie SWITZERLAND 50 ml e / 1.7 FL. OZ. MADE IN SWITZERLAND
Product Labels
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| AVOBENZONE | ACTIVE INGREDIENT | G63QQF2NOX | 9 | |
| OCTINOXATE | ACTIVE INGREDIENT | 4Y5P7MUD51 | 9 | |
| OCTISALATE | ACTIVE INGREDIENT | 4X49Y0596W | 9 | |
| OXYBENZONE | ACTIVE INGREDIENT | 95OOS7VE0Y | 9 | |
| AVOBENZONE | ACTIVE MOIETY | G63QQF2NOX | 9 | |
| OCTINOXATE | ACTIVE MOIETY | 4Y5P7MUD51 | 9 | |
| OCTISALATE | ACTIVE MOIETY | 4X49Y0596W | 9 | |
| OXYBENZONE | ACTIVE MOIETY | 95OOS7VE0Y | 9 | |
| .ALPHA.-AMYLCINNAMALDEHYDE | INACTIVE INGREDIENT | WC51CA3418 | 9 | |
| ALCOHOL | INACTIVE INGREDIENT | 3K9958V90M | 9 | |
| ASIAN GINSENG | INACTIVE INGREDIENT | CUQ3A77YXI | 9 | |
| BENZOIC ACID | INACTIVE INGREDIENT | 8SKN0B0MIM | 9 | |
| BENZYL ALCOHOL | INACTIVE INGREDIENT | LKG8494WBH | 9 | |
| BENZYL BENZOATE | INACTIVE INGREDIENT | N863NB338G | 9 | |
| BENZYL SALICYLATE | INACTIVE INGREDIENT | WAO5MNK9TU | 9 | |
| BUTYLENE GLYCOL | INACTIVE INGREDIENT | 3XUS85K0RA | 9 | |
| BUTYLPHENYL METHYLPROPIONAL | INACTIVE INGREDIENT | T7540GJV69 | 9 | |
| CARNOSINE | INACTIVE INGREDIENT | 8HO6PVN24W | 9 | |
| CHLORPHENESIN | INACTIVE INGREDIENT | I670DAL4SZ | 9 | |
| COCO GLUCOSIDE | INACTIVE INGREDIENT | ICS790225B | 9 | |
| CYCLOMETHICONE 5 | INACTIVE INGREDIENT | 0THT5PCI0R | 9 | |
| CYCLOMETHICONE 6 | INACTIVE INGREDIENT | XHK3U310BA | 9 | |
| DIETHYLENE GLYCOL MONOETHYL ETHER | INACTIVE INGREDIENT | A1A1I8X02B | 9 | |
| DIMETHICONE | INACTIVE INGREDIENT | 92RU3N3Y1O | 9 | |
| ECHIUM PLANTAGINEUM SEED OIL | INACTIVE INGREDIENT | PIB7XBU8XW | 9 | |
| EDETATE DISODIUM | INACTIVE INGREDIENT | 7FLD91C86K | 9 | |
| ETHYLPARABEN | INACTIVE INGREDIENT | 14255EXE39 | 9 | |
| EUGENOL | INACTIVE INGREDIENT | 3T8H1794QW | 9 | |
| GERANIOL | INACTIVE INGREDIENT | L837108USY | 9 | |
| GLYCERIN | INACTIVE INGREDIENT | PDC6A3C0OX | 9 | |
| GLYCERYL MONOSTEARATE | INACTIVE INGREDIENT | 230OU9XXE4 | 9 | |
| GLYCINE | INACTIVE INGREDIENT | TE7660XO1C | 9 | |
| HYDROXYCITRONELLAL | INACTIVE INGREDIENT | 8SQ0VA4YUR | 9 | |
| ISOMETHYL-.ALPHA.-IONONE | INACTIVE INGREDIENT | 9XP4LC555B | 9 | |
| ISONONYL ISONONANOATE | INACTIVE INGREDIENT | S4V5BS6GCX | 9 | |
| LAUROYL LYSINE | INACTIVE INGREDIENT | 113171Q70B | 9 | |
| LINALOOL, DL- | INACTIVE INGREDIENT | D81QY6I88E | 9 | |
| MEDIUM-CHAIN TRIGLYCERIDES | INACTIVE INGREDIENT | C9H2L21V7U | 9 | |
| METHYLPARABEN | INACTIVE INGREDIENT | A2I8C7HI9T | 9 | |
| MICA | INACTIVE INGREDIENT | V8A1AW0880 | 9 | |
| PEG-100 STEARATE | INACTIVE INGREDIENT | YD01N1999R | 9 | |
| PHENOXYETHANOL | INACTIVE INGREDIENT | HIE492ZZ3T | 9 | |
| POTASSIUM SORBATE | INACTIVE INGREDIENT | 1VPU26JZZ4 | 9 | |
| PROPYLENE GLYCOL | INACTIVE INGREDIENT | 6DC9Q167V3 | 9 | |
| SERINE | INACTIVE INGREDIENT | 452VLY9402 | 9 | |
| SUCROSE | INACTIVE INGREDIENT | C151H8M554 | 9 | |
| URSOLIC ACID | INACTIVE INGREDIENT | P3M2575F3F | 9 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 9 | |
| XANTHAN GUM | INACTIVE INGREDIENT | TTV12P4NEE | 9 |
Products#
Every source-derived product name is available through these pages.
- ANTI-AGING SUNSCREEN BROAD SPECTRUM SPF 30
- AVOBENZONE, OCTINOXATE, OCTISALATE, OXYBENZONE
- WATER
- BUTYLENE GLYCOL
- GLYCERIN
- COCO GLUCOSIDE
- CYCLOMETHICONE 6
- DIETHYLENE GLYCOL MONOETHYL ETHER
- PEG-100 STEARATE
- ISONONYL ISONONANOATE
- GLYCERYL MONOSTEARATE
- ASIAN GINSENG
- URSOLIC ACID
- MEDIUM-CHAIN TRIGLYCERIDES
- SERINE
- CARNOSINE
- GLYCINE
- CYCLOMETHICONE 5
- PROPYLENE GLYCOL
- DIMETHICONE
- ECHIUM PLANTAGINEUM SEED OIL
- LAUROYL LYSINE
- SUCROSE
- XANTHAN GUM
- EDETATE DISODIUM
- ALCOHOL
- MICA
- BENZYL ALCOHOL
- LINALOOL, (+/-)-
- HYDROXYCITRONELLAL
- ISOMETHYL-.ALPHA.-IONONE
- .ALPHA.-AMYLCINNAMALDEHYDE
- GERANIOL
- BENZYL BENZOATE
- BUTYLPHENYL METHYLPROPIONAL
- EUGENOL
- BENZYL SALICYLATE
- PHENOXYETHANOL
- POTASSIUM SORBATE
- CHLORPHENESIN
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 68026-502 | 68026-502-50, 68026-502-05 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CLOTH / TOPICAL | 0.05 mg/mg | ||
| PHENOXYETHANOL | PHENOXYETHANOL | HIE492ZZ3T | AEROSOL, FOAM / TOPICAL | 72 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | DROPS / AURICULAR (OTIC) | 0.05 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL, METERED / RESPIRATORY (INHALATION) | 26664 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | INJECTION, POWDER, FOR SUSPENSION / INTRAVENOUS | 900 mg | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | SUSPENSION / OPHTHALMIC | 2 mg | ||
| BENZYL ALCOHOL | BENZYL ALCOHOL | LKG8494WBH | INJECTION, SOLUTION / SUBCUTANEOUS | 0.95 %w/v | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | JELLY / TOPICAL | 420 mg | ||
| BENZYL ALCOHOL | BENZYL ALCOHOL | LKG8494WBH | INJECTION / SUBCONJUNCTIVAL | 252 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION / INTRADERMAL | 1.6 %w/v | ||
| SUCROSE | SUCROSE | C151H8M554 | INJECTION, EMULSION / INTRAVENOUS | 970 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | SUSPENSION, EXTENDED RELEASE / ORAL | 5400 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION, CONCENTRATE / INTRAVENOUS | 4000 mg | ||
| GLYCINE | GLYCINE | TE7660XO1C | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 200 mg | ||
| BENZYL ALCOHOL | BENZYL ALCOHOL | LKG8494WBH | LIQUID / INTRAVENOUS | 1.04 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | PASTE / DENTAL | 20 %w/w | ||
| MEDIUM-CHAIN TRIGLYCERIDES | MEDIUM-CHAIN TRIGLYCERIDES | C9H2L21V7U | SOLUTION / ORAL | 5566 mg | ||
| BENZOIC ACID | BENZOIC ACID | 8SKN0B0MIM | CREAM / TOPICAL | 6 mg | ||
| GLYCINE | GLYCINE | TE7660XO1C | POWDER, FOR SUSPENSION / ORAL | 400 mg | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | GRANULE, FOR SUSPENSION, EXTENDED RELEASE / ORAL | 2350 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | EMULSION / OPHTHALMIC | 1.5 %w/v | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | INJECTION / INFILTRATION | 80 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL / DENTAL | 1.8 %w/w | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | INJECTION, SUSPENSION / SUBCUTANEOUS | 0.16 %w/v | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | SUSPENSION / RECTAL | 1808 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | ENEMA / RECTAL | 60 mg | ||
| BENZYL ALCOHOL | BENZYL ALCOHOL | LKG8494WBH | SUSPENSION / TOPICAL | 1 %w/w | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SUSPENSION/ DROPS / OPHTHALMIC | 1 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | SOLUTION / ORAL | 346 mg | ||
| GLYCERYL MONOSTEARATE | GLYCERYL MONOSTEARATE | 230OU9XXE4 | OINTMENT / TOPICAL | 5 %w/w | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | SOLUTION / ORAL | 1000 mg/15ml | ||
| BENZOIC ACID | BENZOIC ACID | 8SKN0B0MIM | SUPPOSITORY / VAGINAL | 2 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL / TOPICAL | 561 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | SUSPENSION/ DROPS / OPHTHALMIC | 0.05 %w/w | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | INJECTION, SUSPENSION / INTRAMUSCULAR | 1 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | INJECTION / SUBCUTANEOUS | 22 mg | ||
| GLYCERYL MONOSTEARATE | GLYCERYL MONOSTEARATE | 230OU9XXE4 | SUSPENSION / AURICULAR (OTIC) | 0.5 %w/v | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | INJECTION / SUBCUTANEOUS | 6 mg | ||
| GLYCINE | GLYCINE | TE7660XO1C | CAPSULE, DELAYED RELEASE / ORAL | 50 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SYSTEM / IONTOPHORESIS | 0.1 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | TABLET, DELAYED RELEASE / ORAL | NA | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | TABLET, EFFERVESCENT / ORAL | 32 mg | ||
| GLYCINE | GLYCINE | TE7660XO1C | INJECTION / INTRAVENOUS | 200 mg | ||
| BENZYL ALCOHOL | BENZYL ALCOHOL | LKG8494WBH | GEL / VAGINAL | 100 mg | ||
| BENZOIC ACID | BENZOIC ACID | 8SKN0B0MIM | CREAM / VAGINAL | 10 mg | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | POWDER, FOR SUSPENSION / ORAL | 600 mg | ||
| GLYCINE | GLYCINE | TE7660XO1C | TABLET, CHEWABLE / ORAL | 267 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | INJECTION / INTRAVENOUS | 10 %w/v | ||
| BENZOIC ACID | BENZOIC ACID | 8SKN0B0MIM | SUSPENSION / ORAL | 15 mg | ||
| BENZOIC ACID | BENZOIC ACID | 8SKN0B0MIM | SOLUTION / TOPICAL | 0.1 %w/w | ||
| BUTYLENE GLYCOL | BUTYLENE GLYCOL | 3XUS85K0RA | SYSTEM / TRANSDERMAL | 8.12 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | SUSPENSION / ORAL | 48209 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | DROPS / NASAL | 10 mg/1ml | ||
| CYCLOMETHICONE 5 | CYCLOMETHICONE 5 | 0THT5PCI0R | AEROSOL / TOPICAL | 2.5 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / ORAL | 32400 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SUSPENSION/ DROPS / OPHTHALMIC | 0.75 %w/v | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | TABLET, FILM COATED / ORAL | 4 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | INJECTION, POWDER, FOR SOLUTION / INTRAMUSCULAR | 3.6 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SOLUTION / RESPIRATORY (INHALATION) | 43 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SOLUTION / DENTAL | 2 %w/w |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 764e92fa-cfb7-bf98-e053-2991aa0aa3e6 | 234d9d0a-6222-42dd-92c9-0dced63e945f | 2018-09-20 | Warnings | 764e92fa-cfb7-bf98-e053-2991aa0aa3e6 234d9d0a-6222-42dd-92c9-0dced63e945f |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.